PG04 Update on COPD exacerbations

Postgraduate Course
Chairs: G. Caramori (Ferrara, Italy), S. Sethi (Buffalo, United States of America)
Aims: Over the past few years, significant progress has been made in understanding the pathophysiology and treatment of exacerbations in patients with COPD. The aims of the session are as follows:
• To describe the pathophysiological changes that occur during exacerbation;
• To review the use of biomarkers that are predictive of the frequent exacerbation phenotype;
• To highlight the role of antibiotics in the treatment of AECOPD; and
• To describe the newer treatment approaches for AECOPD.

HERMES SYLLABUS LINKS
ADULT: Module B.1 Airway diseases

---

Educational Material

How to access educational materials from mobile devices

---

Clinical assessment and staging of COPD exacerbations J. Vestbo (Hellerup, Denmark)
The role of bacteria in COPD exacerbations J. Wedzicha (London, United Kingdom)
Viral infections and COPD exacerbations P. Mallia (London, United Kingdom)
Therapeutic options for COPD exacerbations R. Lutter (Amsterdam, Netherlands)